Marimed (MRMD) Operating Leases (2019 - 2026)

Marimed (MRMD) has reported Operating Leases for 8 consecutive years, with $8.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Operating Leases fell 6.34% year-over-year to $8.5 million in Q2 2026; TTM through Jun 2026 was $8.5 million, a 6.34% decrease from a year earlier, with the FY2025 full-year figure at $6.6 million, down 12.36% from the prior year.
• Operating Leases was $8.5 million for Q2 2026 at Marimed, up from $8.4 million in the prior quarter.
• Over five years, Operating Leases peaked at $10.6 million in Q1 2023 and troughed at $4.2 million in Q4 2022.
• A 5-year average of $8.3 million and a median of $8.7 million in 2025 frame the typical range for Operating Leases.
• Across the five-year window, Operating Leases jumped 102.61% in 2023 and decreased 12.36% in 2025, its largest moves.
• Over 5 years, Operating Leases stood at $4.2 million in 2022, then jumped by 102.61% to $8.5 million in 2023, then dropped by 10.72% to $7.5 million in 2024, then slipped by 12.36% to $6.6 million in 2025, then rose by 28.61% to $8.5 million in 2026.
• The last three Operating Leases figures came in at $8.5 million (Q2 2026), $8.4 million (Q1 2026), and $6.6 million (Q4 2025), per Business Quant data.